DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Amphetamine (Amphetamine) - Published Studies

 
 



Amphetamine Related Published Studies

Well-designed clinical trials related to Amphetamine

Interactions between bupropion and 3,4-methylenedioxymethamphetamine in healthy subjects. [2015]

Effect of extended-release dexmethylphenidate and mixed amphetamine salts on sleep: a double-blind, randomized, crossover study in youth with attention-deficit hyperactivity disorder. [2014]

State dependent effect of transcranial direct current stimulation (tDCS) on methamphetamine craving. [2014]

A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD). [2013]

Cigarette smoking as a target for potentiating outcomes for methamphetamine abuse treatment. [2013]

A retrospective analysis of two randomized trials of bupropion for methamphetamine dependence: suggested guidelines for treatment discontinuation/augmentation. [2012]

Dexamphetamine improves upper extremity outcome during rehabilitation after stroke: a pilot randomized controlled trial. [2011.10]

Medication adherence and symptom reduction in adults treated with mixed amphetamine salts in a randomized crossover study. [2011.09]

The influence of depression on treatment for methamphetamine use. [2011.08.01]

Quality of life among treatment seeking methamphetamine-dependent individuals. [2011.07]

Functional magnetic resonance imaging investigation of the amphetamine sensitization model of schizophrenia in healthy male volunteers. [2011.06]

Comparison of the behavioral and cardiovascular effects of intranasal and oral d-amphetamine in healthy human subjects. [2011.06]

Bulimia nervosa among methamphetamine dependent adults: association with outcomes three years after treatment. [2011.05]

Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals. [2011.04]

The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. [2011.04]

Zinc for attention-deficit/hyperactivity disorder: placebo-controlled double-blind pilot trial alone and combined with amphetamine. [2011.02]

A randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addiction. [2011.02]

Acute effects of MDMA (3,4-methylenedioxymethamphetamine) on EEG oscillations: alone and in combination with ethanol or THC (delta-9-tetrahydrocannabinol). [2011.02]

Methamphetamine dependence treatment rehabilitation in Thailand: a model assessment. [2011.01]

Minocycline attenuates subjective rewarding effects of dextroamphetamine in humans. [2011.01]

Dose effects and comparative effectiveness of extended release dexmethylphenidate and mixed amphetamine salts. [2011]

Acute modafinil effects on attention and inhibitory control in methamphetamine-dependent humans. [2011]

Urinary excretion kinetics of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its phase I and phase II metabolites in humans following controlled MDMA administration. [2011]

Poor response to sertraline in methamphetamine dependence is associated with sustained craving for methamphetamine. [2011]

A randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addiction. [2011]

Contingency management to reduce methamphetamine use and sexual risk among men who have sex with men: a randomized controlled trial. [2010.12.20]

Is ecstasy an "empathogen"? Effects of +/-3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others. [2010.12.15]

Investigating the mechanisms of hallucinogen-induced visions using 3,4-methylenedioxyamphetamine (MDA): a randomized controlled trial in humans. [2010.12.02]

Serum ferritin and amphetamine response in youth with attention-deficit/hyperactivity disorder. [2010.12]

The effects of modafinil treatment on neuropsychological and attentional bias performance during 7-day inpatient withdrawal from methamphetamine dependence. [2010.12]

Amphetamine-related improvement in executive function in patients with chronic schizophrenia is modulated by practice effects. [2010.12]

Sustained release d-amphetamine reduces cocaine but not 'speedball'-seeking in buprenorphine-maintained volunteers: a test of dual-agonist pharmacotherapy for cocaine/heroin polydrug abusers. [2010.12]

A double-blind, placebo-controlled study of N-acetyl cysteine plus naltrexone for methamphetamine dependence. [2010.11]

Anxiety disorders among methamphetamine dependent adults: association with post-treatment functioning. [2010.09]

Effect of D-amphetamine on inhibition and motor planning as a function of baseline performance. [2010.09]

The angiotensin-converting enzyme inhibitor perindopril treatment alters cardiovascular and subjective effects of methamphetamine in humans. [2010.08.30]

Estimating the intake of abused methamphetamines using experimenter-administered deuterium labeled R-methamphetamine: selection of the R-methamphetamine dose. [2010.08]

Modafinil administration improves working memory in methamphetamine-dependent individuals who demonstrate baseline impairment. [2010.07]

Predictors and consequences of incarceration among a sample of young Thai methamphetamine users. [2010.07]

Verbal memory improved by D-amphetamine: influence of the testing effect. [2010.07]

Stress-induced changes in mood and cortisol release predict mood effects of amphetamine. [2010.06.01]

Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence. [2010.06.01]

Use of an acute challenge with d-amphetamine to model cognitive improvement in chronic schizophrenia. [2010.06]

Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high-risk men who have sex with men. [2010.04.24]

Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. [2010.04.01]

Psychosocial treatment for methamphetamine use disorders: a preliminary randomized controlled trial of cognitive behavior therapy and Acceptance and Commitment Therapy. [2010.04]

It's the thought that counts: craving metacognitions and their role in abstinence from methamphetamine use. [2010.04]

Neurochemical alterations in methamphetamine-dependent patients treated with cytidine-5'-diphosphate choline: a longitudinal proton magnetic resonance spectroscopy study. [2010.04]

Cocaine choice in humans during D-amphetamine maintenance. [2010.04]

Polymorphisms in dopamine transporter (SLC6A3) are associated with stimulant effects of D-amphetamine: an exploratory pharmacogenetic study using healthy volunteers. [2010.03]

Pharmacokinetics of lisdexamfetamine dimesylate and its active metabolite, d-amphetamine, with increasing oral doses of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: a single-dose, randomized, open-label, crossover study. [2010.02]

Are attention lapses related to d-amphetamine liking? [2010.02]

More aroused, less fatigued: fatty acid amide hydrolase gene polymorphisms influence acute response to amphetamine. [2010.02]

Stereoselectivity in the human metabolism of methamphetamine. [2010.02]

Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers. [2010.01.15]

Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence. [2010.01]

Amphetamine-related improvement in executive function in patients with chronic schizophrenia is modulated by practice effects. [2010]

Estimating the intake of abused methamphetamines using experimenter-administered deuterium labeled R-methamphetamine: selection of the R-methamphetamine dose. [2010]

Use of an acute challenge with d-amphetamine to model cognitive improvement in chronic schizophrenia. [2010]

Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high-risk men who have sex with men. [2010]

Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers. [2010]

Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants. [2009.12]

Predicting adherence to treatment for methamphetamine dependence from neuropsychological and drug use variables. [2009.11.01]

The cardiovascular and subjective effects of methamphetamine combined with gamma-vinyl-gamma-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteers. [2009.11]

Double-blind study of dextroamphetamine versus caffeine augmentation for treatment-resistant obsessive-compulsive disorder. [2009.11]

Further evidence of association between amphetamine response and SLC6A2 gene variants. [2009.10]

Effects of omeprazole on the pharmacokinetic profiles of lisdexamfetamine dimesylate and extended-release mixed amphetamine salts in adults. [2009.09]

Performance and subjective effects of diazepam and d-amphetamine in high and low sensation seekers. [2009.09]

Preventing growth in amphetamine use: long-term effects of the Midwestern Prevention Project (MPP) from early adolescence to early adulthood. [2009.08.04]

The effects of L-amphetamine sulfate on cognition in MS patients: results of a randomized controlled trial. [2009.07]

Correlates of incarceration among young methamphetamine users in Chiang Mai, Thailand. [2009.07]

Amphetamine-induced place preference in humans. [2009.05.15]

Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial. [2009.04.01]

Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up. [2009.04]

A randomized, double-blind, placebo-controlled trial assessing the impact of dexamphetamine on fatigue in patients with advanced cancer. [2009.04]

The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects. [2009.03]

Sustaining executive functions during sleep deprivation: A comparison of caffeine, dextroamphetamine, and modafinil. [2009.02.01]

A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence. [2009.02]

Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy. [2009.01.01]

Evaluation of a peer network intervention trial among young methamphetamine users in Chiang Mai, Thailand. [2009.01]

Risk factors associated with methamphetamine use and heart failure among native Hawaiians and other Pacific Island peoples. [2009]

Atomoxetine attenuates dextroamphetamine effects in humans. [2009]

Effects of oral methamphetamine on cocaine use: A randomized, double-blind, placebo-controlled trial. [2008.12.04]

Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers. [2008.12]

Methylphenidate and amphetamine do not induce cytogenetic damage in lymphocytes of children with ADHD. [2008.12]

Attention-deficit/hyperactivity disorder-specific quality of life with triple-bead mixed amphetamine salts (SPD465) in adults: Results of a randomized, double-blind, placebo-controlled study. [2008.11.04]

Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial. [2008.11]

Attention-deficit/hyperactivity disorder-specific quality of life with triple-bead mixed amphetamine salts (SPD465) in adults: results of a randomized, double-blind, placebo-controlled study. [2008.11]

Adolescent methamphetamine use and sexual risk behaviour in secondary school students in Cape Town, South Africa. [2008.11]

Restoration of risk-propensity during sleep deprivation: caffeine, dextroamphetamine, and modafinil. [2008.09]

Disulfiram enhances subjective effects of dextroamphetamine in humans. [2008.09]

Triple-bead mixed amphetamine salts (SPD465), a novel, enhanced extended-release amphetamine formulation for the treatment of adults with ADHD: a randomized, double-blind, multicenter, placebo-controlled study. [2008.09]

Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness. [2008.09]

Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence. [2008.07]

Acute physiological and behavioral effects of intranasal methamphetamine in humans. [2008.07]

Effects of l-amphetamine sulfate on cognitive function in multiple sclerosis patients. [2008.06]

Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge. [2008.06]

A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal. [2008.05]

The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers. [2008.04]

Bupropion for the treatment of methamphetamine dependence. [2008.04]

The explicit learning of new names for known objects is improved by dexamphetamine. [2008.03]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017